PharmaShots | Incisive News in 3 Shots

Subscribe Now

Late Onset Pompe Disease

Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) Receives the US FDA's Approval for the Treatment of Late-Onset Pompe Disease

Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) Receives the US FDA's Approval for the Treatment of Late-Onset Pompe Disease

August 9, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us